Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.94 Million AUD | 71.48% |
| 2023 | -20.84 Million AUD | -10.0% |
| 2022 | -23.69 Million AUD | -4.17% |
| 2021 | -5.84 Million AUD | 11.02% |
| 2020 | -4.52 Million AUD | -3.34% |
| 2019 | -15.59 Million AUD | -49.44% |
| 2018 | -18.93 Million AUD | -225.34% |
| 2017 | -3.13 Million AUD | -358.68% |
| 2016 | -699.72 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 57.42% |
| 2024 Q4 | -2.34 Million AUD | 0.0% |
| 2024 Q2 | -3.46 Million AUD | 0.0% |
| 2023 Q2 | -8.82 Million AUD | 0.0% |
| 2023 Q4 | -7.61 Million AUD | 0.0% |
| 2023 FY | - AUD | -10.0% |
| 2022 FY | - AUD | -4.17% |
| 2022 Q2 | -6.4 Million AUD | 0.0% |
| 2022 Q4 | -8.54 Million AUD | 0.0% |
| 2021 Q2 | -7.32 Million AUD | 0.0% |
| 2021 FY | - AUD | 11.02% |
| 2021 Q4 | -8.32 Million AUD | 0.0% |
| 2020 Q2 | -9.63 Million AUD | 0.0% |
| 2020 FY | - AUD | -3.34% |
| 2020 Q4 | -6.49 Million AUD | 0.0% |
| 2019 Q4 | -8.14 Million AUD | 0.0% |
| 2019 FY | - AUD | -49.44% |
| 2019 Q2 | -4.19 Million AUD | 0.0% |
| 2018 Q4 | -5.51 Million AUD | 0.0% |
| 2018 FY | - AUD | -225.34% |
| 2018 Q2 | -4 Million AUD | 0.0% |
| 2017 Q3 | -753.91 Thousand AUD | 33.96% |
| 2017 FY | - AUD | -358.68% |
| 2017 Q2 | -1.14 Million AUD | 0.0% |
| 2017 Q4 | -1.94 Million AUD | -157.56% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 157.303% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -308.158% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 83.685% |
| Biome Australia Limited | -1.57 Million AUD | -276.714% |
| Patrys Limited | -3.49 Million AUD | -70.253% |
| Orthocell Limited | -11.68 Million AUD | 49.102% |
| Imugene Limited | -147.97 Million AUD | 95.982% |
| PYC Therapeutics Limited | -38.11 Million AUD | 84.402% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 47.384% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 17.259% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 24.62% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 40.248% |
| CSL Limited | 4.73 Billion AUD | 100.126% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 32.691% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -99.849% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 111.464% |
| Starpharma Holdings Limited | -12.57 Million AUD | 52.727% |
| Nanollose Limited | -1.14 Million AUD | -417.944% |
| Memphasys Limited | -3.3 Million AUD | -79.746% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -725.257% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -230.988% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -30.395% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 57.286% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -110.974% |
| Race Oncology Limited | -14.2 Million AUD | 58.14% |
| Nyrada Inc. | -4.59 Million AUD | -29.357% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 125.888% |
| Dimerix Limited | -24.95 Million AUD | 76.179% |
| PharmAust Limited | -9.45 Million AUD | 37.096% |
| Immutep Limited | -42.87 Million AUD | 86.133% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 86.684% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 69.622% |
| BTC Health Limited | 1.05 Million AUD | 663.4% |
| Acrux Limited | -7.93 Million AUD | 25.035% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 102.984% |
| Biotron Limited | -5.04 Million AUD | -17.965% |
| Tissue Repair Ltd | -5.77 Million AUD | -2.952% |
| AdAlta Limited | -5.3 Million AUD | -12.122% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 86.897% |
| Hexima Limited | -995.54 Thousand AUD | -497.211% |
| AnteoTech Limited | -11.57 Million AUD | 48.617% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 90.788% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 72.158% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -83.361% |
| Actinogen Medical Limited | -12.92 Million AUD | 53.986% |
| Immuron Limited | -6.19 Million AUD | 3.987% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -213.318% |